New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
17:35 EDTVTLVital Therapies reports Q2 EPS (91c), may not compare to consensus (55c)
Based on its current business plan, the company believes its existing cash and cash equivalents as of June 30, along with the net proceeds from its IPO will be sufficient to fund its operations into the second quarter of 2016.
News For VTL From The Last 14 Days
Check below for free stories on VTL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 10, 2014
10:00 EDTVTLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:03 EDTVTLVital Therapies downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
September 8, 2014
08:11 EDTVTLVital Therapies announces enrollment in VTI-208 trial 75% complete
As of today, 150 of a targeted 200 subjects have been enrolled in VTI-208, our randomized, controlled Phase 3 clinical trial in alcohol induced liver decompensation. Enrollment rates remain consistent with prior projections, and preliminary results are expected in the first half of 2015. Forty-nine clinical sites are now open in the USA, UK, Spain and Australia, and 38 sites have enrolled at least one subject.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use